14.09.2020
Intralymphatic Immunotherapy improves grass pollen allergic rhinoconjunctivitis. A three-year randomized placebo-controlled trial
Skaarup S.H. i wsp.
J Allergy Clin Immunol. 2020 Jul 14;S0091-6749(20)30964-7. doi: 10.1016/j.jaci.2020.07.002